Sign In
Buy NPCE
$15.88
-0.410 (-2.52%)
At Close: Jun 03, 2026
What Makes NeuroPace (NPCE) a New Buy Stock
01:00pm, Monday, 18'th Nov 2024
NeuroPace (NPCE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade
11:00am, Monday, 18'th Nov 2024
The mean of analysts' price targets for NeuroPace (NPCE) points to a 54.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys
NeuroPace, Inc. (NPCE) Q3 2024 Earnings Call Transcript
07:59pm, Tuesday, 12'th Nov 2024
NeuroPace, Inc. (NASDAQ:NPCE ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Jeremy Feffer – Investor Relations Joel Becker – Chief Executive Officer Rebecca K
NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates
07:06pm, Tuesday, 12'th Nov 2024
NeuroPace, Inc. (NPCE) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.28 per share a year ago.
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
04:05pm, Monday, 04'th Nov 2024
The RNS System Post-Approval Study (PAS) is the largest prospective post-approval study in neuromodulation for patients with drug - resistant focal epilepsy
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength?
09:05am, Monday, 28'th Oct 2024
NeuroPace (NPCE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r
NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024
04:05pm, Tuesday, 22'nd Oct 2024
MOUNTAIN VIEW, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it w
NeuroPace Continues to Strengthen Management Team
04:05pm, Wednesday, 16'th Oct 2024
Appoints experienced people leader as Vice President of Human Resources Appoints experienced people leader as Vice President of Human Resources
NeuroPace Strengthens Management Team with Two Key Appointments
04:05pm, Wednesday, 04'th Sep 2024
Appointed former key developer of RNS System as new Vice President of Research and Development Appointed former head of commercial marketing for Boston Scientific's DBS franchise as the new Vice Presi
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
04:05pm, Tuesday, 27'th Aug 2024
MOUNTAIN VIEW, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it w
NeuroPace to Participate in Upcoming Healthcare Conferences in September
04:05pm, Thursday, 22'nd Aug 2024
MOUNTAIN VIEW, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it w
NeuroPace: Only For Those With Strong Nerves
01:01pm, Tuesday, 20'th Aug 2024
NeuroPace, Inc. aims to improve the lives of epilepsy patients with RNS technology, addressing drug-resistant epilepsy. The company has seen revenue growth, but continues to post losses nonetheless. N
NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up
08:40am, Tuesday, 20'th Aug 2024
NeuroPace's (NPCE) top and bottom lines outpace estimates in the second quarter.
NeuroPace, Inc. (NPCE) Q2 2024 Earnings Call Transcript
10:22pm, Tuesday, 13'th Aug 2024
NeuroPace, Inc. (NASDAQ:NPCE ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Jeremy Feffer - Managing Director, LifeSci Advisors Joel Becker - Chief Executive Office
NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024
04:05pm, Tuesday, 23'rd Jul 2024
MOUNTAIN VIEW, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it w
